An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
about
Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureusAntibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolutionCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Antimicrobial action of water-soluble β-chitosan against clinical multi-drug resistant bacteria.Efflux as a glutaraldehyde resistance mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa biofilmsEfflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them.Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps.An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria.Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.Serovar Typhi in Bangladesh: Exploration of Genomic Diversity and Antimicrobial Resistance
P2860
Q26829852-19AB58B2-FFBE-4883-8857-B74F15E1BC9CQ28484201-37FA669D-E890-4352-8B0D-D91529D47EF9Q33659230-CE1A9F81-7D89-48AC-9B46-04FDD7AE931CQ35482558-364FBF11-BF24-4937-BD7C-D014317E5ABDQ35585591-E0067AB3-7EBA-4F51-984C-B7FD73E04DB2Q35607771-70BD44A7-F82F-491B-95A4-C3E4FC4A242BQ37428456-C232CBF7-7677-464D-BE94-9C7FFEF5BBEAQ37697676-3DEE9270-1FD6-48D2-8371-40AE6C9A1582Q38011247-1F45DAE6-2442-4A47-A232-837AFCA5DDC7Q38056146-83A2ED04-A5E9-49C1-BB97-D9586D7DA480Q38099322-1D2340AC-31C6-4F53-ABFC-78044513C28DQ38715925-EEA922A3-4177-4826-9E7A-3CCF781DC238Q38872081-ACC28911-EF7C-46B7-8FC0-7719D2330A37Q40763094-CD15902D-A941-4A31-96AD-43A6EF26974EQ48208855-872FFE43-C98D-4B33-980D-35C20F6CF20EQ50035189-EC847721-CC9C-462C-9FB8-F87E20A94E77Q59132666-87611372-C40A-4070-8B15-35354DDAD3D1
P2860
An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An original deal for new molec ...... m-negative resistant bacteria.
@ast
An original deal for new molec ...... m-negative resistant bacteria.
@en
type
label
An original deal for new molec ...... m-negative resistant bacteria.
@ast
An original deal for new molec ...... m-negative resistant bacteria.
@en
prefLabel
An original deal for new molec ...... m-negative resistant bacteria.
@ast
An original deal for new molec ...... m-negative resistant bacteria.
@en
P1476
An original deal for new molec ...... am-negative resistant bacteria
@en
P2093
P304
P356
10.2174/092986711796150469
P577
2011-01-01T00:00:00Z